Canada markets closed

ChromaDex Corporation (CDXC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.0600+0.1400 (+7.29%)
At close: 04:00PM EDT
1.8000 -0.26 (-12.62%)
After hours: 07:45PM EDT

ChromaDex Corporation

10900 Wilshire Boulevard
Suite 600
Los Angeles, CA 90024
United States
310 388 6706
https://www.chromadex.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees115

Key Executives

NameTitlePayExercisedYear Born
Mr. Frank Louis Jaksch Jr.Co-Founder & Chairman504.3kN/A1968
Mr. Robert N. FriedCEO & Director679.87kN/A1960
Mr. Kevin M. Farr CPACFO, Principal Financial & Accounting Officer410.62kN/A1958
Dr. Andrew Shao Ph.D.Sr. VP of Global Regulatory & Scientific AffairsN/AN/AN/A
Brianna GerberVP of Fin. & Investor RelationsN/AN/AN/A
Alex WorshamVP of Global Marketing & CommunicationsN/AN/AN/A
Mr. Fadi KaramChief Marketing OfficerN/AN/AN/A
David KroesSr. VP of People MattersN/AN/AN/A
Ms. Chu YanManaging Director of Asia PacificN/AN/AN/A
Mr. William CarterSr. VP of Bus. AffairsN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.

Corporate Governance

ChromaDex Corporation’s ISS Governance QualityScore as of July 31, 2022 is 6. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 3; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.